INTRODUCTION
A contract research organization (CRO) providing experimental testing services under current good manufacturing practices (cGMP) can expect to enter into numerous quality agreements (QAG) with pharmaceutical industry clients (sponsors). These agreements, usually initiated by the client, are intended to ensure that the CRO addresses key client concerns according to client requirements. For example, concerns may include issues such as timely client notification for a confirmed out-of-specification (OOS) result. More generally, the CRO must support promises made by the client to a regulatory...
This content is only available to IVT members.
Get help maintaining your knowledge in GMP - Supplier Management. Read More!
If you are already a member and you do not have access to this article, upgrade your membership.
Need help? Read our FAQs.
This product has been added to your shopping cart. You can
continue shopping or proceed to
checkout.